Cargando…
Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort
BACKGROUND: Atypical hyperplasia (AH) and mammographic breast density (MBD) are established risk factors for breast cancer (BC), but their joint contributions are not well understood. We examine associations of MBD and BC by histologic impression, including AH, in a subcohort of women from the Mayo...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282712/ https://www.ncbi.nlm.nih.gov/pubmed/28143431 http://dx.doi.org/10.1186/s12885-017-3082-2 |
_version_ | 1782503377205198848 |
---|---|
author | Vierkant, Robert A. Degnim, Amy C. Radisky, Derek C. Visscher, Daniel W. Heinzen, Ethan P. Frank, Ryan D. Winham, Stacey J. Frost, Marlene H. Scott, Christopher G. Jensen, Matthew R. Ghosh, Karthik Manduca, Armando Brandt, Kathleen R. Whaley, Dana H. Hartmann, Lynn C. Vachon, Celine M. |
author_facet | Vierkant, Robert A. Degnim, Amy C. Radisky, Derek C. Visscher, Daniel W. Heinzen, Ethan P. Frank, Ryan D. Winham, Stacey J. Frost, Marlene H. Scott, Christopher G. Jensen, Matthew R. Ghosh, Karthik Manduca, Armando Brandt, Kathleen R. Whaley, Dana H. Hartmann, Lynn C. Vachon, Celine M. |
author_sort | Vierkant, Robert A. |
collection | PubMed |
description | BACKGROUND: Atypical hyperplasia (AH) and mammographic breast density (MBD) are established risk factors for breast cancer (BC), but their joint contributions are not well understood. We examine associations of MBD and BC by histologic impression, including AH, in a subcohort of women from the Mayo Clinic Benign Breast Disease Cohort. METHODS: Women with a diagnosis of BBD and mammogram between 1985 and 2001 were eligible. Histologic impression was assessed via pathology review and coded as non-proliferative disease (NP), proliferative disease without atypia (PDWA) and AH. MBD was assessed clinically using parenchymal pattern (PP) or BI-RADS criteria and categorized as low, moderate or high. Percent density (PD) was also available for a subset of women. BC and clinical information were obtained by questionnaires, medical records and the Mayo Clinic Tumor Registry. Women were followed from date of benign biopsy to BC, death or last contact. Standardized incidence ratios (SIRs) compared the observed number of BCs to expected counts. Cox regression estimated multivariate-adjusted MBD hazard ratios. RESULTS: Of the 6271 women included in the study, 1132 (18.0%) had low MBD, 2921 (46.6%) had moderate MBD, and 2218 (35.4%) had high MBD. A total of 3532 women (56.3%) had NP, 2269 (36.2%) had PDWA and 470 (7.5%) had AH. Over a median follow-up of 14.3 years, 528 BCs were observed. The association of MBD and BC risk differed by histologic impression (p-interaction = 0.03), such that there was a strong MBD and BC association among NP (p < 0.001) but non-significant associations for PDWA (p = 0.27) and AH (p = 0.96). MBD and BC associations for AH women were not significant within subsets defined by type of MBD measure (PP vs. BI-RADS), age at biopsy, number of foci of AH, type of AH (lobular vs. ductal) and body mass index, and after adjustment for potential confounding variables. Women with atypia who also had high PD (>50%) demonstrated marginal evidence of increased BC risk (SIR 4.98), but results were not statistically significant. CONCLUSION: We found no evidence of an association between MBD and subsequent BC risk in women with AH. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3082-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5282712 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-52827122017-02-03 Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort Vierkant, Robert A. Degnim, Amy C. Radisky, Derek C. Visscher, Daniel W. Heinzen, Ethan P. Frank, Ryan D. Winham, Stacey J. Frost, Marlene H. Scott, Christopher G. Jensen, Matthew R. Ghosh, Karthik Manduca, Armando Brandt, Kathleen R. Whaley, Dana H. Hartmann, Lynn C. Vachon, Celine M. BMC Cancer Research Article BACKGROUND: Atypical hyperplasia (AH) and mammographic breast density (MBD) are established risk factors for breast cancer (BC), but their joint contributions are not well understood. We examine associations of MBD and BC by histologic impression, including AH, in a subcohort of women from the Mayo Clinic Benign Breast Disease Cohort. METHODS: Women with a diagnosis of BBD and mammogram between 1985 and 2001 were eligible. Histologic impression was assessed via pathology review and coded as non-proliferative disease (NP), proliferative disease without atypia (PDWA) and AH. MBD was assessed clinically using parenchymal pattern (PP) or BI-RADS criteria and categorized as low, moderate or high. Percent density (PD) was also available for a subset of women. BC and clinical information were obtained by questionnaires, medical records and the Mayo Clinic Tumor Registry. Women were followed from date of benign biopsy to BC, death or last contact. Standardized incidence ratios (SIRs) compared the observed number of BCs to expected counts. Cox regression estimated multivariate-adjusted MBD hazard ratios. RESULTS: Of the 6271 women included in the study, 1132 (18.0%) had low MBD, 2921 (46.6%) had moderate MBD, and 2218 (35.4%) had high MBD. A total of 3532 women (56.3%) had NP, 2269 (36.2%) had PDWA and 470 (7.5%) had AH. Over a median follow-up of 14.3 years, 528 BCs were observed. The association of MBD and BC risk differed by histologic impression (p-interaction = 0.03), such that there was a strong MBD and BC association among NP (p < 0.001) but non-significant associations for PDWA (p = 0.27) and AH (p = 0.96). MBD and BC associations for AH women were not significant within subsets defined by type of MBD measure (PP vs. BI-RADS), age at biopsy, number of foci of AH, type of AH (lobular vs. ductal) and body mass index, and after adjustment for potential confounding variables. Women with atypia who also had high PD (>50%) demonstrated marginal evidence of increased BC risk (SIR 4.98), but results were not statistically significant. CONCLUSION: We found no evidence of an association between MBD and subsequent BC risk in women with AH. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3082-2) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-31 /pmc/articles/PMC5282712/ /pubmed/28143431 http://dx.doi.org/10.1186/s12885-017-3082-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Vierkant, Robert A. Degnim, Amy C. Radisky, Derek C. Visscher, Daniel W. Heinzen, Ethan P. Frank, Ryan D. Winham, Stacey J. Frost, Marlene H. Scott, Christopher G. Jensen, Matthew R. Ghosh, Karthik Manduca, Armando Brandt, Kathleen R. Whaley, Dana H. Hartmann, Lynn C. Vachon, Celine M. Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort |
title | Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort |
title_full | Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort |
title_fullStr | Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort |
title_full_unstemmed | Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort |
title_short | Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort |
title_sort | mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the mayo clinic benign breast disease (bbd) cohort |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282712/ https://www.ncbi.nlm.nih.gov/pubmed/28143431 http://dx.doi.org/10.1186/s12885-017-3082-2 |
work_keys_str_mv | AT vierkantroberta mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort AT degnimamyc mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort AT radiskyderekc mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort AT visscherdanielw mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort AT heinzenethanp mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort AT frankryand mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort AT winhamstaceyj mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort AT frostmarleneh mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort AT scottchristopherg mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort AT jensenmatthewr mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort AT ghoshkarthik mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort AT manducaarmando mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort AT brandtkathleenr mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort AT whaleydanah mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort AT hartmannlynnc mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort AT vachoncelinem mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort |